Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1979 Aug;42(8):734–740. doi: 10.1136/jnnp.42.8.734

Lymphocyte function in myasthenia gravis.

S Kawanami, A Kanaide, Y Itoyama, Y Kuroiwa
PMCID: PMC490307  PMID: 490180

Abstract

Mitogen-induced blastoid transformation of peripheral blood lymphocytes from patients with myasthenia gravis was studied using a microplate culture technique and evaluated with 3H-thymidine incorporation. It was found that both phytohaemagglutinin and pokeweed mitogen responses decreased significantly in patients with myasthenia gravis. In myasthenic crisis, indices of stimulation by phytohaemagglutination became very low. The autologous plasma neither inhibited nor facilitated mitogenic responses of lymphocytes. The decreased mitogen responsiveness of lymphocytes suggests that part of the T lymphocyte function is subnormal in myasthenia.

Full text

PDF
734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Lisak R. P., Zweiman B., Abrahamsohn I., Penn A. S. The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med. 1974 Dec 12;291(24):1271–1275. doi: 10.1056/NEJM197412122912403. [DOI] [PubMed] [Google Scholar]
  2. Abramsky O., Aharonov A., Webb C., Fuchs S. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol. 1975 Jan;19(1):11–16. [PMC free article] [PubMed] [Google Scholar]
  3. Adner M. M., Isé C., Schwab R., Sherman J. D., Dameshek W. Immunologic studies of thymectomized and nonthymectomized patients with myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):536–554. doi: 10.1111/j.1749-6632.1966.tb45501.x. [DOI] [PubMed] [Google Scholar]
  4. Almon R. R., Andrew C. G., Appel S. H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science. 1974 Oct 4;186(4158):55–57. doi: 10.1126/science.186.4158.55. [DOI] [PubMed] [Google Scholar]
  5. Alpert L. I., Rule A., Norio M., Kott E., Kornfeld P., Osserman K. E. Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle. Am J Clin Pathol. 1972 Dec;58(6):647–653. doi: 10.1093/ajcp/58.6.647. [DOI] [PubMed] [Google Scholar]
  6. Armstrong R. M., Nowak R. M., Falk R. E. Thymic lymphocyte function in myasthenia gravis. Neurology. 1973 Oct;23(10):1078–1083. doi: 10.1212/wnl.23.10.1078. [DOI] [PubMed] [Google Scholar]
  7. Basch R. S., Goldstein G. Antigenic and functional evidence for the in vitro inductive activity of thymopoietin (thymin) on thymocyte precursors. Ann N Y Acad Sci. 1975 Feb 28;249:290–299. doi: 10.1111/j.1749-6632.1975.tb29076.x. [DOI] [PubMed] [Google Scholar]
  8. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):496–505. doi: 10.1111/j.1749-6632.1966.tb45497.x. [DOI] [PubMed] [Google Scholar]
  9. Clot J., Massip H., Mathieu O. In Vitro studies on human B and T cell purified populations. Stimulation by mitogens and allogeneic cells, and quantitative binding of phytomitogens. Immunology. 1975 Sep;29(3):445–453. [PMC free article] [PubMed] [Google Scholar]
  10. Goldstein G., Schlesinger D. H. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Lancet. 1975 Aug 9;2(7928):256–259. doi: 10.1016/s0140-6736(75)90966-6. [DOI] [PubMed] [Google Scholar]
  11. Goust J. M., Castaigne A., Moulias R. Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis. Clin Exp Immunol. 1974 Sep;18(1):39–47. [PMC free article] [PubMed] [Google Scholar]
  12. Hammarström L., Smith E., Möller E., Franksson C., Matell G., Von Reis G. Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol. 1975 Aug;21(2):202–215. [PMC free article] [PubMed] [Google Scholar]
  13. Houseley J., Oppenheim J. J. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. Br Med J. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hsu C. C. Comparative inhibitory effects of serum on lymphocyte responses to mitogenic stimulation. Int Arch Allergy Appl Immunol. 1976;50(1):14–26. doi: 10.1159/000231476. [DOI] [PubMed] [Google Scholar]
  15. JOSKE R. A. The effects of thymectomy on the lymphocyte count in patients with myasthenia gravis. Med J Aust. 1958 Dec 27;45(26):859–861. [PubMed] [Google Scholar]
  16. KORNFELD P., SIEGAL S., WEINER L. B., OSSERMAN K. E. STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS. Ann Intern Med. 1965 Sep;63:416–428. doi: 10.7326/0003-4819-63-3-416. [DOI] [PubMed] [Google Scholar]
  17. Kawanami S., Itoyama Y., Kuroiwa Y. Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy. J Neurol. 1976 Jul 15;213(1):33–40. doi: 10.1007/BF00316337. [DOI] [PubMed] [Google Scholar]
  18. Knight S., Bradley J., Oppenheim J. J., Ling N. R. The in vitro transformation of thymocytes and lymphocytes from humans, rabbits and guinea-pigs and from thymomas. Clin Exp Immunol. 1968 May;3(4):323–341. [PMC free article] [PubMed] [Google Scholar]
  19. Knoke J., Kanaide A., Powell A. E. Modulation of lymphocytic responses by factors in human plasma. I. The effects on normal, stimulated lymphocytes of various normal plasmas in microplate culture. Int Arch Allergy Appl Immunol. 1974;46(4):584–599. doi: 10.1159/000231159. [DOI] [PubMed] [Google Scholar]
  20. Konda S., Stockert E., Smith R. T. Immunologic properties of mouse thymus cells: membrane antigen patterns associated with various cell subpopulations. Cell Immunol. 1973 May;7(2):275–289. doi: 10.1016/0008-8749(73)90250-5. [DOI] [PubMed] [Google Scholar]
  21. Lindstrom J. M., Lennon V. A., Seybold M. E., Whittingham S. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci. 1976;274:254–274. doi: 10.1111/j.1749-6632.1976.tb47691.x. [DOI] [PubMed] [Google Scholar]
  22. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
  23. Lisak R. P., Zweiman B. Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis. J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):521–524. doi: 10.1136/jnnp.38.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. MILLER J. F. Immunological function of the thymus. Lancet. 1961 Sep 30;2(7205):748–749. doi: 10.1016/s0140-6736(61)90693-6. [DOI] [PubMed] [Google Scholar]
  25. Mellstedt H. In vitro activation of human T and B lymphocytes by pokeweed mitogen. Clin Exp Immunol. 1975 Jan;19(1):75–82. [PMC free article] [PubMed] [Google Scholar]
  26. Mendelsohn J., Multer M. M., Bernheim J. L. Inhibition of human lymphocyte stimulation by steroid hormones: cytokinetic mechanisms. Clin Exp Immunol. 1977 Jan;27(1):127–134. [PMC free article] [PubMed] [Google Scholar]
  27. Monnier V. M., Fulpius B. W. A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol. 1977 Jul;29(1):16–22. [PMC free article] [PubMed] [Google Scholar]
  28. Moretta L., Ferrarini M., Mingari M. C., Moretta A., Webb S. R. Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol. 1976 Dec;117(6):2171–2174. [PubMed] [Google Scholar]
  29. Morimoto C. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1978 Apr;32(1):125–133. [PMC free article] [PubMed] [Google Scholar]
  30. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  31. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  32. Namba T., Arimori S., Grob D. Lymphocytes of patients with myasthenia gravis. Local effects in rats following intramuscular administration. Arch Neurol. 1969 Sep;21(3):285–295. doi: 10.1001/archneur.1969.00480150075010. [DOI] [PubMed] [Google Scholar]
  33. Newberry W. M., Shorey J. W., Sanford J. P., Combes B. Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell Immunol. 1973 Jan;6(1):87–97. doi: 10.1016/0008-8749(73)90009-9. [DOI] [PubMed] [Google Scholar]
  34. Shirai T., Miyata M., Nakase A., Itoh T. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis. Clin Exp Immunol. 1976 Oct;26(1):118–123. [PMC free article] [PubMed] [Google Scholar]
  35. Simpson J. A., Behan P. O., Dick H. M. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci. 1976;274:382–389. doi: 10.1111/j.1749-6632.1976.tb47699.x. [DOI] [PubMed] [Google Scholar]
  36. Stout R. D., Herzenberg L. A. The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor. J Exp Med. 1975 Nov 1;142(5):1041–1051. doi: 10.1084/jem.142.5.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yata J., Tsukimoto I., Tachibana T. Human lymphocyte subpopulations. Human thymus-lymphoid tissue (HTL) antigen-positive lymphocytes forming rosettes with sheep erythrocytes and HTL antigen-negative lymphocytes interacting with antigen-antibody-complement complexes. Clin Exp Immunol. 1973 Jul;14(3):319–326. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES